SIK3
Basic information
Region (hg38): 11:116843402-117098437
Links
Phenotypes
GenCC
Source:
- autism (Limited), mode of inheritance: AD
- hearing loss disorder (Limited), mode of inheritance: AD
- spondyloepimetaphyseal dysplasia, Krakow type (Limited), mode of inheritance: AR
- spondyloepimetaphyseal dysplasia, Krakow type (Limited), mode of inheritance: Unknown
- spondyloepimetaphyseal dysplasia, Krakow type (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spondyloepimetaphyseal dysplasia, Krakow type | AR | Allergy/Immunology/Infectious | The condition can include immunodeficiency, and awareness may allow antiinfectious prophylaxis and early and aggressive treatment of infection | Allergy/Immunology/Infectious; Endocrine; Musculoskeletal; Neurologic | 30232230 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (135 variants)
- not_provided (17 variants)
- SIK3-related_disorder (17 variants)
- Spondyloepimetaphyseal_dysplasia,_Krakow_type (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIK3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001366686.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 14 | 2 | 22 | ||
| missense | 1 | 1 | 137 | 11 | 1 | 151 |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 6 | 6 | ||||
| Total | 1 | 1 | 149 | 25 | 3 |
Highest pathogenic variant AF is 6.84149e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SIK3 | protein_coding | protein_coding | ENST00000292055 | 23 | 255036 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125733 | 0 | 15 | 125748 | 0.0000596 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.83 | 524 | 741 | 0.707 | 0.0000420 | 8338 |
| Missense in Polyphen | 145 | 289.33 | 0.50117 | 3448 | ||
| Synonymous | -0.440 | 298 | 288 | 1.03 | 0.0000169 | 2450 |
| Loss of Function | 6.85 | 3 | 60.5 | 0.0496 | 0.00000275 | 688 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00107 | 0.000580 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000354 | 0.0000352 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- LKB1 signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.312
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.6
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene ontology
- Biological process
- microtubule cytoskeleton organization;protein phosphorylation;intracellular signal transduction
- Cellular component
- cytoplasm
- Molecular function
- magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding;tau-protein kinase activity